A Phase 1 Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of AM0010 in Healthy Adult Subjects
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2017
At a glance
- Drugs Ilodecakin (Primary)
- Indications Breast cancer; Colorectal cancer; Fibrosis; Hypercholesterolaemia; Inflammatory bowel diseases; Malignant melanoma; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer; Renal cancer
- Focus Pharmacokinetics
- Sponsors Amro
- 23 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 05 Sep 2017 Status changed from not yet recruiting to recruiting.
- 01 Sep 2017 New trial record